Clinical Trial Update: Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD [Phase 3]

View source ↗

Summary

Phase 3 trial update for TREAT-CAD evaluating biomarkers and antithrombotic treatment in cervical artery dissection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Artery Dissection

Snippet

Sponsor: Stefan Engelter | Conditions: Cervical Artery Dissection | Phase 3 | Status: COMPLETED